Many patients believe brand-name drugs are always safer than generics. But that’s a misunderstanding.Drug safety depends on regulation, not branding.What’s the Difference?An orig...
September 30, 2025 — Gilead’s Epclusa (sofosbuvir/velpatasvir, 400mg/100mg) continues to reshape hepatitis C management worldwide. As the first and only all-oral, pan-genotypi...